Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Anabolic treatment for osteoporosis: teriparatide.

Eastell R, Walsh JS.

Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):173-178. doi: 10.11138/ccmbm/2017.14.1.173. Epub 2017 Oct 25. Review.

2.

The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.

Cianferotti L, Bertoldo F, Carini M, Kanis JA, Lapini A, Longo N, Martorana G, Mirone V, Reginster JY, Rizzoli R, Brandi ML.

Oncotarget. 2017 May 18;8(43):75646-75663. doi: 10.18632/oncotarget.17980. eCollection 2017 Sep 26. Review.

3.

Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats.

Shimizu T, Tanaka T, Kobayashi T, Kudo I, Nakatsugawa M, Takakura A, Takao-Kawabata R, Ishizuya T.

Bone Rep. 2017 Aug 19;7:70-82. doi: 10.1016/j.bonr.2017.06.001. eCollection 2017 Dec.

4.

Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health.

Golds G, Houdek D, Arnason T.

Int J Endocrinol. 2017;2017:4602129. doi: 10.1155/2017/4602129. Epub 2017 Mar 16. Review.

5.

Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.

Yano T, Yamada M, Inoue D.

Calcif Tissue Int. 2017 Jul;101(1):102-110. doi: 10.1007/s00223-017-0263-6. Epub 2017 Mar 23.

6.

Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review.

Kim SM, Kang KC, Kim JW, Lim SJ, Hahn MH.

J Bone Metab. 2017 Feb;24(1):65-73. doi: 10.11005/jbm.2017.24.1.65. Epub 2017 Feb 28.

7.

Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.

Leder BZ.

Curr Osteoporos Rep. 2017 Apr;15(2):110-119. doi: 10.1007/s11914-017-0353-4. Review.

PMID:
28303448
8.

Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.

Takeda S, Sakai S, Tanaka K, Tomizawa H, Serizawa K, Yogo K, Urayama K, Hashimoto J, Endo K, Matsumoto Y.

Calcif Tissue Int. 2017 Jul;101(1):65-74. doi: 10.1007/s00223-017-0255-6. Epub 2017 Feb 28.

9.

The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials.

Lou S, Lv H, Wang G, Zhang L, Li M, Li Z, Zhang L, Tang P.

Biomed Res Int. 2016;2016:6040379. doi: 10.1155/2016/6040379. Epub 2016 Jun 26. Review.

10.

Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS).

Langdahl BL, Ljunggren Ö, Benhamou CL, Marin F, Kapetanos G, Kocjan T, Lespessailles E, Napoli N, Nikolic T, Petto H, Moll T, Lindh E.

Calcif Tissue Int. 2016 Sep;99(3):259-71. doi: 10.1007/s00223-016-0143-5. Epub 2016 Apr 30.

11.

Teriparatide in Fracture Non-Unions.

Coppola C, Del Buono A, Maffulli N.

Transl Med UniSa. 2014 Sep 1;12:47-53. eCollection 2015 May-Aug.

12.

Osteoporosis in men: a review.

Adler RA.

Bone Res. 2014 Apr 29;2:14001. doi: 10.1038/boneres.2014.1. eCollection 2014. Review.

13.

Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS).

Aloumanis K, Kapetanos G, Bartzis N, Drossinos V; Hellenic ExFOS study group.

BMC Musculoskelet Disord. 2015 Jun 5;16:136. doi: 10.1186/s12891-015-0600-8.

14.

Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis.

Chen LX, Zhou ZR, Li YL, Ning GZ, Zhang TS, Zhang D, Feng SQ.

PLoS One. 2015 May 26;10(5):e0128032. doi: 10.1371/journal.pone.0128032. eCollection 2015.

15.

The clinical epidemiology of male osteoporosis: a review of the recent literature.

Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J.

Clin Epidemiol. 2015 Jan 9;7:65-76. doi: 10.2147/CLEP.S40966. eCollection 2015. Review.

16.

Treatment of primary osteoporosis in men.

Giusti A, Bianchi G.

Clin Interv Aging. 2014 Dec 30;10:105-15. doi: 10.2147/CIA.S44057. eCollection 2015. Review.

17.

Teriparatide treatment of osteoporosis in an HIV-infected man: a case report and literature review.

Wheeler AL, Tien PC, Grunfeld C, Schafer AL.

AIDS. 2015 Jan 14;29(2):245-6. doi: 10.1097/QAD.0000000000000529. Review. No abstract available.

18.
19.

Male osteoporosis: clinical approach and management in family practice.

Goh LH, How CH, Lau TC.

Singapore Med J. 2014 Jul;55(7):353-7.

20.

Osteoporosis in men: epidemiology and treatment with denosumab.

Sidlauskas KM, Sutton EE, Biddle MA.

Clin Interv Aging. 2014 Apr 8;9:593-601. doi: 10.2147/CIA.S51940. eCollection 2014. Review.

Supplemental Content

Support Center